These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14979226)

  • 1. Establishing safe injection facilities in Canada: legal and ethical issues.
    Elliott R; Malkin I; Gold J
    Can HIV AIDS Policy Law Rev; 2002 Mar; 6(3):7-10. PubMed ID: 14979226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health Canada commits to strengthening efforts with respect to injection drug use and HIV/AIDS.
    Jürgens R
    Can HIV AIDS Policy Law Rev; 2001; 6(1-2):86-9. PubMed ID: 11837044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of policy in community pharmacies' response to injection-drug use: results of a nationwide Canadian survey.
    Myers T; Cockerill R; Millson M; Rankin J; Worthington C
    AIDS Public Policy J; 1996; 11(2):78-88. PubMed ID: 10915241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug policy in Canada--the way forward.
    Kerr T; O'Briain W
    Can HIV AIDS Policy Law Rev; 2002 Jul; 7(1):1, 27-32. PubMed ID: 14765475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making.
    Hyshka E; Bubela T; Wild TC
    Addiction; 2013 Mar; 108(3):468-76. PubMed ID: 23286831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacist perspectives on HIV/AIDS and interventions for injection drug users in Canada.
    Myers T; Cockerill R; Worthington C; Millson M; Rankin J
    AIDS Care; 1998 Dec; 10(6):689-700. PubMed ID: 9924524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gay and lesbian legal issues and HIV/AIDS: a discussion paper.
    Can HIV AIDS Policy Law Newsl; 1997-1998 Winter; 3-4(4-1):6-9. PubMed ID: 11365298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Legal and ethical issues in microbicides research and development in Canada.
    Alexandrova A
    Can HIV AIDS Policy Law Rev; 2004 Aug; 9(2):39-42. PubMed ID: 15540344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection drug use, HIV/AIDS and incarceration: evidence from the Vancouver Injection Drug Users Study.
    Small W; Wood E; Jürgens R; Kerr T
    HIV AIDS Policy Law Rev; 2005 Dec; 10(3):1, 5-10. PubMed ID: 16544394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Injection Drug Use: New Trends and Prominent Issues.
    Roy É; Arruda N; Bruneau J; Jutras-Aswad D
    Can J Psychiatry; 2016 Mar; 61(3):136-44. PubMed ID: 27254088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
    Kerr T; Small W; Moore D; Wood E
    Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safe injection facilities in Canada: is it time?
    Kerr T; Palepu A
    CMAJ; 2001 Aug; 165(4):436-7. PubMed ID: 11531053
    [No Abstract]   [Full Text] [Related]  

  • 13. Report on complementary/alternative health care and HIV/AIDS.
    Crouch R; Elliott R; Lemmens T; Charland L
    Can HIV AIDS Policy Law Rev; 2002 Mar; 6(3):10-2. PubMed ID: 14979227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside.
    Kerr T; Wood E; Small D; Palepu A; Tyndall MW
    CMAJ; 2003 Oct; 169(8):759-63. PubMed ID: 14557313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV vaccines in Canada: legal and ethical issues--an overview.
    Garmaise D
    Can HIV AIDS Policy Law Rev; 2002 Jul; 7(1):26-7. PubMed ID: 14765483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of safer injection facilities in reducing HIV and hepatitis C infections and overdose mortality in the United States.
    Semaan S; Fleming P; Worrell C; Stolp H; Baack B; Miller M
    Drug Alcohol Depend; 2011 Nov; 118(2-3):100-10. PubMed ID: 21515001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV/AIDS in prisons: recent developments.
    Jürgens R
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):13-20. PubMed ID: 14719487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harm reduction, HIV/AIDS, and the human rights challenge to global drug control policy.
    Elliott R; Csete J; Wood E; Kerr T
    Health Hum Rights; 2005; 8(2):104-38. PubMed ID: 17136905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harm-reduction activism: a case study of an unsanctioned user-run safe injection site.
    Kerr T; Oleson M; Wood E
    Can HIV AIDS Policy Law Rev; 2004 Aug; 9(2):13-9. PubMed ID: 15540324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection drug users' access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture.
    Small W; Shoveller J; Moore D; Tyndall M; Wood E; Kerr T
    Qual Health Res; 2011 Jun; 21(6):743-56. PubMed ID: 21378259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.